VIVEVE MEDICAL, INC. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Provision for doubtful accounts
Depreciation and amortization
Stock-based compensation
Fair value of common shares issued
Non-cash interest expense
Amortization of operating lease right-of-use assets and accretion of operating lease liabilities
Loss from minority interest in limited liability company
Loss on disposal of property and equipment
Modification of warrants
Forgiveness of Paycheck Protection Program loan

Changes in assets and liabilities:
Accounts receivable
Inventory
Prepaid expenses and other current assets
Other noncurrent assets
Accounts payable
Accrued and other liabilities
Other noncurrent liabilities
Net cash used in operating activities
Cash flows from investing activities:
Purchase of property and equipment
Investment in limited liability company
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from note payable
Repayments of note payable
Proceeds from exercise of common warrants
Proceeds from purchase of common shares under Purchase Agreement with LPC
Proceeds from Paycheck Protection Program loan
Proceeds from issuance of common shares from employee stock purchase plan
Proceeds from exercise of stock options
Transaction costs in connection with note payable
Reverse stock split - cancellation and payout of fractional shares
Net cash provided by financing activities
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents - beginning of period
Cash and cash equivalents - end of period

Supplemental disclosure:
Cash paid for interest
Cash paid for income taxes
Supplemental disclosure of cash flow information as of end of period:
Issuance of warrants in connection with note payable
Forgiveness of Paycheck Protection Program loan
Issuance of Series B convertible preferred stock in settlement of dividends
Issuance of note payable in settlement of accrued interest
Net transfer of equipment between inventory and property and equipment
Issuance of Series B convertible preferred stock and common stock warrants in connection with debt conversion
Operating cash outflows from operating leases
Right-of-use assets obtained in exchange for operating lease liabilities (upon adoption of ASC 842)

Comments